and had a growth stock to match but ceded its leads to competitors such as Boston Scientific and Abbott Laboratories , Barron's reported. With its stock at a 10-year low, Medtronic wants to create and buy new products and technology to beef up its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Medtronic's cheap shares may leap: report
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account